“Why the ‘rebound effect’ has become the surgeon’s best ally against Ozempic
In the last two years, the GLP-1 receptor agonists like for example Ozempic either wegovy have gone from being drugs for diabetes to becoming the cultural and medical phenomenon of the decade for fight obesity. And such was its impact, that it was thought that surgery for obesity had come to an end, but the … Read more